Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Health-care product for treating cardiovascular and cerebralvascular disease

A technology for cardiovascular and cerebrovascular diseases and health care products, applied in cardiovascular system diseases, blood diseases, extracellular fluid diseases, etc., can solve problems such as large side effects and single effect, and achieve significant effects, no toxic side effects, and high content of active ingredients. Effect

Inactive Publication Date: 2006-08-09
张恩及
View PDF0 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0013] An object of the present invention is to solve the problem of large side effects and single effect of the medicines or health products used for cardiovascular and cerebrovascular diseases in the above-mentioned prior art, and to provide a kind of medicine with comprehensive nutritional components and remarkable effects of prevention and auxiliary treatment. Health products for cardiovascular and cerebrovascular diseases

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0084] 25 tons of selenium-enriched yeast; 150 tons of chelated calcium aspartate; 150 tons of chelated magnesium aspartate; 20 tons of chelated zinc glycinate; 300 tons of potassium L-aspartate; 0.15 tons of folic acid; 25 tons of linolenic acid dry powder; 90 tons of natto freeze-dried powder; 50 tons of ginkgo biloba extract; 50 tons of ginger extract; 100 tons of celery extract; 50 tons of rhodiola extract; 50 tons of valerian extract;

[0085] Excipients can also be added to the above raw materials to facilitate the manufacture of tablets. Excipients: 130 tons of microcrystalline cellulose, magnesium stearate and dextrin.

[0086] 1. Crush the above raw materials and auxiliary materials to 80-200 mesh;

[0087] 2. Put the above raw materials and auxiliary materials together in the mixing tank and mix them thoroughly;

[0088] 3. Feed the material in the tablet press, and the tablet is ready;

Embodiment 2

[0090] Selenium-enriched yeast 25mg (50 micrograms of selenium); chelated calcium aspartate (10% calcium) 150mg (Ca: 15mg); chelated magnesium aspartate (10% magnesium) 150mg (Containing Mg: 15mg); chelated zinc glycinate (containing 20% ​​zinc) 20mg (containing Zn: 4mg); potassium L-aspartate (containing approximately 16% potassium) 300mg (containing K: 50mg); Folic acid 0.1mg (100μg); ephedrine dry powder 25mg (containing linolenic acid: 20mg); Natto freeze-dried powder 100mg; Ginkgo biloba extract 50mg; Ginger extract 50mg; Celery extract 100mg; Rhodiola rosea extract 50mg; Valerian extract 50mg; excipients: microcrystalline cellulose, magnesium stearate, and dextrin are prepared in a weight ratio of 70:10:20, totaling 130mg.

[0091] Prepared according to the method described in Example 1.

Embodiment 3-9

[0093] Examples 3-9 were prepared according to the method described in Example 1, and the proportions are shown in Table 1.

[0094] Raw material (kg)

Example 3

Example 4

Example 5

Example 6

Example 7

Example 8

Example 9

Selenium-enriched yeast

15

35

20

25

30

28

22

Chelated calcium aspartate

100

200

150

120

180

140

160

Chelated Magnesium Aspartate

100

200

180

140

160

150

120

Chelated zinc glycinate

10

30

15

20

25

22

18

Potassium L-Aspartate

200

400

250

350

300

280

330

Folic acid

0.01

1

0.02

0.05

0.1

0.2

0.5

Linolenic acid dry powder

28

22

15

35

20

25

30

Natto freeze-dried powder

50

150

80

100

120

90

110

Gink...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a health care product for cardiovascular diseases and cerebrovascular disease that is made up from Se rich yeast, chelate type asparagic acid Ca, chelate type asparagic acid Mg, chelate type glycine Zn, L-asparagic acid K, folic acid, linolenic acid dried powder, bean frozen dried powder, ginkgo leaf extract, fresh ginger extract, celery extract, rhodiola root extract, and valerian extract. The invention supplies a health cure product that has comprehensive nutrient content and has prevent and cure effect for cardiovascular diseases and cerebrovascular disease.

Description

Technical field [0001] A health product for cardiovascular and cerebrovascular diseases relates to the field of health products. Background technique [0002] Due to the modern lifestyle, the improvement of living standards and the extension of life span, the incidence and mortality of cardiovascular and cerebrovascular diseases are increasing day by day, and they have become the number one killer of human diseases. At present, 8-10 million people die every year from cardiovascular and cerebrovascular diseases caused by arteriosclerosis. Among the morbidity and mortality of various diseases in the United States, thrombosis ranks first, and its mortality rate is 5 times higher than that of cancer. In my country, there are currently 110-130 million patients with hypertension; the incidence of coronary heart disease tends to be younger, and the mortality rate of coronary heart disease is as high as 62%; the age of onset of stroke also tends to be younger, with patients under 50 reac...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/9068A61K31/195A61K31/202A61P9/10A61P7/02
Inventor 张恩及
Owner 张恩及
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com